1169930-49-7 Usage
Uses
3-Furanacetic acid, .alpha.-aminotetrahydrois used as a chemical intermediate in the synthesis of various organic compounds. Its unique structure, which includes both an alpha-amino group and a furanacetic acid moiety, makes it a potentially valuable building block for the development of new pharmaceuticals, agrochemicals, or other specialty chemicals.
Used in Pharmaceutical Industry:
3-Furanacetic acid, .alpha.-aminotetrahydrois used as a precursor in the synthesis of novel drug candidates for potential therapeutic applications. Its incorporation into complex molecules could lead to the discovery of new medicines with unique mechanisms of action.
Used in Agrochemical Industry:
3-Furanacetic acid, .alpha.-aminotetrahydrois used as a starting material in the development of new agrochemicals, such as pesticides or herbicides. Its chemical properties may contribute to the creation of more effective and environmentally friendly products.
Used in Specialty Chemicals Industry:
3-Furanacetic acid, .alpha.-aminotetrahydrois used as a component in the formulation of specialty chemicals, such as dyes, fragrances, or flavorings. Its distinctive chemical structure could enable the production of innovative and high-quality products in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1169930-49-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,9,9,3 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1169930-49:
(9*1)+(8*1)+(7*6)+(6*9)+(5*9)+(4*3)+(3*0)+(2*4)+(1*9)=187
187 % 10 = 7
So 1169930-49-7 is a valid CAS Registry Number.
1169930-49-7Relevant academic research and scientific papers
Potent HIV Protease Inhibitors: The Development of Tetrahydrofuranylglycines as Novel P2 Ligands and Pyrazine Amides as P3-Ligands
Ghosh, Arun K.,Thompson, Wayne J.,Holloway, M. Katharine,McKee, Sean P.,Duong, Tien T.,et al.
, p. 2300 - 2310 (2007/10/02)
A series of protease inhibitors bearing constrained unnaturel amino acids at the P2-position and novel heterocycles at the P3-position of compound 1 (Ro 31-8959) were synthesized, and their in vitro enzyme inhibitory and antiviral ac
